These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 31840653)
1. Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22. Yang X; Tao L; Zhu J; Zhang S Med Sci Monit; 2019 Dec; 25():9609-9617. PubMed ID: 31840653 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy. Jin L; Zhou Y; Han L; Piao J In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):112-119. PubMed ID: 31845077 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway. Zhang M; Jiang Y; Guo X; Zhang B; Wu J; Sun J; Liang H; Shan H; Zhang Y; Liu J; Wang Y; Wang L; Zhang R; Yang B; Xu C J Cell Mol Med; 2019 Nov; 23(11):7685-7698. PubMed ID: 31465630 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis. Li L; Li L; Zhang YZ; Yang HY; Wang YY Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):396-408. PubMed ID: 31957854 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways. Zhang Y; Shang Z; Liu A Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200a-3p Is a Positive Regulator in Cardiac Hypertrophy Through Directly Targeting WDR1 as Well as Modulating PTEN/PI3K/AKT/CREB/WDR1 Signaling. Yang X; Chen G; Chen Z J Cardiovasc Pharmacol; 2019 Nov; 74(5):453-461. PubMed ID: 31651553 [TBL] [Abstract][Full Text] [Related]
7. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy. Shi JY; Chen C; Xu X; Lu Q Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869 [TBL] [Abstract][Full Text] [Related]
9. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy. Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA LNC_000898 Alleviates Cardiomyocyte Apoptosis and Promotes Cardiac Repair After Myocardial Infarction Through Modulating the miR-375/PDK1 Axis. Yan M; Liu Q; Jiang Y; Wang B; Ji Y; Liu H; Xie Y J Cardiovasc Pharmacol; 2020 Jul; 76(1):77-85. PubMed ID: 32398474 [TBL] [Abstract][Full Text] [Related]
11. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling. Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Long Noncoding RNA Li M; Qi C; Song R; Xiong C; Zhong X; Song Z; Ning Z; Song X Mol Cell Biol; 2021 Aug; 41(9):e0058020. PubMed ID: 34228494 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention. Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036 [TBL] [Abstract][Full Text] [Related]
14. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Sun XH; Wang X; Zhang Y; Hui J Thromb Res; 2019 May; 177():23-32. PubMed ID: 30844685 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy. Xu X; Su YL; Shi JY; Lu Q; Chen C Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306 [TBL] [Abstract][Full Text] [Related]
16. Compound Kushen injection attenuates angiotensin II‑mediated heart failure by inhibiting the PI3K/Akt pathway. Wang W; Liu D; Yang L; Chen L; Miao M; Liu Y; Yin Y; Wei M; Liu G; An Y; Zheng M Int J Mol Med; 2023 Mar; 51(3):. PubMed ID: 36734284 [TBL] [Abstract][Full Text] [Related]
17. miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway. Xing X; Guo S; Zhang G; Liu Y; Bi S; Wang X; Lu Q Braz J Med Biol Res; 2020; 53(2):e9106. PubMed ID: 31994603 [TBL] [Abstract][Full Text] [Related]
18. CD38 promotes angiotensin II-induced cardiac hypertrophy. Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p. Ji H; Qu J; Peng W; Yang L Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93. Wo Y; Guo J; Li P; Yang H; Wo J Cardiovasc Pathol; 2018; 35():29-36. PubMed ID: 29747050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]